In vitro alternatives for ocular irritation. by Curren, R D & Harbell, J W
In VitroAlternativesfor Ocular Irritation
Rodger D. Curren and John W. Harbell
Institute for In Vitro Sciences, Inc., Gaithersburg, Maryland
The necessity of using animals to test whether new chemicals and products are eye irritants has
been questioned with increasing frequency and fervor over the last 20 years. During this time
many new nonanimal methods have been proposed as reliable alternatives to the traditional
rabbit (Draize) test. To date, however, none of these nonanimal (in vitro) tests have become
universally accepted as a complete replacement for the Draize test. To understand why a
complete replacement has not been found, one has to first understand the reasonably complex
structure of the eye, the standard Draize scoring scale-which is based on a qualitative
evaluation of three different tissues-the differences between human and rabbit eyes, the
intrinsic variability of the animal test, and the details of the different in vitro tests that have been
proposed as replacements. The in vitro tests vary from relatively simple assays using single cells
to more sophisticated assays that use discarded animal tissue or artificially constructed human
tissue. It is clear that appropriately designed in vitro tests will eventually give more useful
mechanistic information about ocular injury from which we can more comfortably predict the
risk of human eye irritation from new products and ingredients. - Environ Health Perspect
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Introduction
The necessity of using animals to test
whether new chemicals and products are eye
irritants has been questioned with increasing
frequency and fervor over the last 20 years.
Admittedly the questions are very complex,
and strong social, political, ethical, and sci-
entific arguments have been raised on both
sides of the issue. During this process,
numerous nonanimal methods have been
proposed as reliable alternatives to the tradi-
tional animal tests. However, before such
tests come into common use, they must be
carefully evaluated to determine if, in fact,
these newmethods can replace or reduce the
use of whole animals. Such evaluation
involves investigating the basic details of
ocular irritation, reviewing what type of
information is currently obtained from the
animal tests, understanding how the
design of in vitro systems relates to the
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animal model, and only then determining
what real progress has been made in the
search for alternatives to traditional ocular
irritation testing.
Structure ofthe Eye
In interpreting the results from any
toxicologic study, there must be some basic
knowledge ofthe organ system being stud-
ied-at the very least an understanding of
its morphology, cellular constituents, and
normal function-that allows one to deter-
mine whether an injury has occurred and
what the consequences of that injury are.
Because there are many similarities between
the animal and the human eye, and because
the human eye is the organ we are trying to
protect, the human eye will be used here as
an example for the discussion of ocular
structure. Where differences exist between
the eyes of humans and rabbits (the usual
target species of ocular irritation testing),
theywill be noted.
Figure 1 depicts a human eye in both
a normal front view and in cross section.
The latter view more clearly shows the
tissues that are of concern to toxicolo-
gists and ophthalmologists. Perhaps the
most important tissue is the cornea: the
exterior surface that is exposed to the
outside environment. The normally
transparent cornea allows light to freely
enter the eye and eventually be focused
on the retina. If the cornea becomes
cloudy (opaque)-as can happen after
accidental exposure to strongly irritating
chemicals-light can no longer pass
easily into the eye and vision becomes
impaired or even completely blocked.
Although the eyelids offer the cornea
some protection, it is still very susceptible
to injury.
About 80% ofthe cornea's structure is
the stroma-a regular array ofmacromole-
cules through which light can easily pass as
a consequence of the stroma's high degree
of order and exact level of hydration.
Maintenance of this very important
hydration level (75-80% water) is the
responsibility of two active cell layers, a
single-cell-thick endothelium covering the
inside surface of the cornea and a much
thicker epithelium that covers the outside
surface. These cell layers work together to
keep additional water from entering the
cornea, which would result in swelling and
opacity. The epithelium also has a second
function of providing a physical barrier
against the entry of foreign materials. If
the epithelium is injured, corneal opacity
can result. However, minor opacities can
often be reversed because the epithelium
can repair itself either by movement of
surrounding cells to cover the wound or
by the actual replacement ofdamaged tis-
sue through new cell division. In contrast,
the endothelium is generally not capable
of repair. Therefore, if these cells suffer
cytotoxic damage there can be significant
consequences, e.g., permanent blindness.
It is this relationship between the induc-
tion ofcellular damage and resulting ocu-
lar irritation or other injury that is the
basis for many of our current in vitro
ocular irritation screening systems.
Another delicate tissue ofthe eye is the
conjunctiva, the nonkeratinized squamous
r- Cornea
. Conjunctivr -
*"~ Iris
Human eye
Figure 1. Tissues ofthe eye, diagram ofthe human eye.
A cross section through the center of the eye is shown
on the left and the normal frontview is on the right. The
three major tissues of interest for eye irritation studies
are illustrated.
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epithelium that lines the inner surfaces of
the eyelids and much of the external sur-
face of the ocular globe (it is continuous
with the cornea). The conjunctiva is highly
vascularized and may become quite
inflamed after exposure to irritating mater-
ial. Mildly irritating chemicals or other
products often cause conjunctivitis without
anyassociated corneal damage.
A third important ocular tissue is the
iris (the colored part ofthe eye), which, by
constricting or dilating, controls the
amount of light that enters the eye and is
eventually focused on the retina. The iris
lies under the cornea within the aqueous
humor. In some cases foreign materials
penetrate completely through the cornea
and interact with the iris. The iris may then
become very inflamed and may lose its abil-
ity to react to light, seriously damaging the
ability to see.
Observations ofthe degree ofinjury to
each of these tissues in the animal model
are incorporated as part ofthe scoring sys-
tem ofmost common eye irritation proto-
cols. The details of these scoring systems
will be discussed in "In Vivo Ocular
IrritationTesting."
In VivoOcular Irritation
Testing
It is important to understand how
manufacturers assure themselves that their
products will not pose an unacceptable
risk to the eyes of their customers.
Generally the process consists of several
steps. First, the maximum potential hazard
of the ingredient or formulation to the
ocular tissue is determined. Second, the
actual use of the product is considered,
estimating the probability that it may inad-
vertently enter the eye. Third, a final safety
assessment takes into account benefits,
risks, and the impact ofthe instructions for
use that generally accompany the product.
Although the entire process is important, it
is the first stage of this process-generally
termed hazard identification-and the
development of improved in vitro systems
to detect such hazards that are important
to this discussion.
For obvious ethical reasons, tests using
animals, rather than volunteer human sub-
jects, have generally been used to assist tox-
icologists in determining the degree of
danger a material poses to the eye.Although
it is possible to expose human eyes to
dilute forms of materials whose chemical
properties are well known and generally
regarded as safe, it is obvious because ofthe
risk of severe injury that this cannot be
done with novel materials whose toxic
properties are as yet unknown.
The albino rabbit has historically been
the animal of choice for testing potential
eye irritants, primarily because its large
eyes make it easy to observe damage. In
addition, ithas alargeconjuctival sac (accen-
tuated by loose lids) that easily accepts test
material and holds it against the eyes.
However, because ofseveral striking differ-
ences, the rabbit is far from a perfect model
for humans. One difference is the presence
ofa nictitating membrane, or third eyelid,
in the rabbit. This membrane moves later-
ally across the eye, likely causing the kinet-
ics of removal of many test materials to
differ from humans. Another difference is
that the conjunctival sac of the rabbit is
much larger than in humans, meaning that
more test material can be placed in a rab-
bit's eye than would be likely to ever get
into the human eye during an accidental
exposure. Additionally, the rabbit cornea is
somewhat thinner than that of humans
and there is less tear production to aid in
washing out a foreign material. For these
and other reasons, the rabbit is generally
considered an overly sensitive model for
humans. Although this may be consid-
ered a positive aspect of the rabbit model
because it adds a margin of safety to the
risk assessment, it also presents the prob-
lem ofinappropriate hazard assessment and
suggests that a more predictive model
would be beneficial.
The conduct of the animal test now
needs to be examined in detail to help us
understand the subjective nature ofthe test
and appreciate the difficulties faced in devel-
opingandvalidating in vitromodels. To test
a material for potential ocular irritation, the
lower lid ofthe animal is pulled away from
the eyeball, and 100 p1 ofa liquid (100 mg
ofasolid) is placed in the resulting conjunc-
tival sac. The lids are then held together for
a few seconds to ensure contact between the
test material and the ocular tissues. The ani-
mal's eyes are carefullyobserved, first at 1-hr
and then at 24-hr intervals for up to 14
days. It is important to highlight again a
major difference between the structure ofa
rabbit's eye and that of a human eye.
Because 100 g1 will not fit into the human
eye, the animal's eyes are being exposed to
much more material than might actually
enter the human eye from an accidental
exposure. The low-volume eye test (1),
which uses one-tenth of the material nor-
mally applied to the rabbit eye, is reported
to better predict the response ofhuman eyes
and to beless hazardous to the animal.
The time that the test material is in
contact with the eye is not controlled dur-
ing the Draize test because the material is
only removed by the natural processes of
tearing and blinking. Therefore, time of
exposure maydifferwith each test material,
which makes it difficult to develop an
in vitromodel.
At various standard time periods after
instillation, the three major tissues of the
eye (cornea, conjunctiva, and iris) are
observed macroscopically for injury. Each
tissue is observed for different signs and the
degree ofinjury is recorded according to a
standard scale. For the cornea, the degree of
opacity and the area ofthe eye involved are
recorded. The iris is examined for inflam-
mation and the conjunctiva-a mucus
membrane-is examined for redness,
chemosis, and any exudate. Generally mild
responses of the conjunctiva alone are not
serious unless the test material is designed
to be applied to or aroundthe eyes.
Draize Scoring Scale
The fact that three ocular tissues can be
affected by chemical treatment makes sim-
ple scoringand evaluation ofoculardamage
difficult. Draize (2) proposed in 1944 what
has become a solution to the problem. He
devised an individual numerical scoring sys-
tem for each of the three ocular tissues of
interest and then proposed a specialweight-
ing system to combine the scores into a sin-
gle eye irritation score. Table 1 shows
specifically how Draize reduced the evalua-
tion ofa very complicated type ofinjury to
asingle number.
This awareness of the various ocular
tissues and the ways they respond to injury
is very important because we need to
understand exactly what score an in vitro
eye irritation assay is supposed to predict.
However, the complete Draize scoring sys-
tem is not generally used to dassify materi-
als for regulatory purposes. The European
Union classification scheme, for example,
uses only discrete categories such as R36
(irritating to eyes), and R41 (risk ofserious
Table 1.The Draizetestaforassessing ocular irritation.
Eyetissue Maximum
Cornea score=opacity(0-4)xarea(0-4)x5 80
Iris score=grading value (0-2)x5 10
Conjunctiva score=[redness (0-3)+ 20
edema(04)+discharge (0-3)] x2
Total score 110
&An illustration of how individual subjective observa-
tions of injuryto three oculartissues are converted into
a single numerical score estimating total eye injury.
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damage to eyes) to define the amount of
danger that exposure to a material represents
(3). However, a continuous scale like that of
Draize gives considerably more information
about the severity of the hazard than does
an abbreviated dassification system, and this
prediction of many levels ofseverity is what
most people envisage as being supplied by a
replacement in vitro test.
However, the single number (Draize
score) presented as the eye irritation poten-
tial ofa chemical or formulation is not exact
(4). The subjective nature of the gross
observations made during the scoring ofthe
test, plus normal animal-to-animal variabil-
ity, make it virtually impossible to routinely
reproduce the final Draize score, especially
for midrange irritants. This does not mean
that Draize scores are completely meaning-
less. Repeated trials will generally generate
scores within an acceptable range. However,
a single Draize score should not be viewed
as an exact predictor of eye irritation poten-
tial. Bruner et al. (5) presented a summary
ofthe effect ofthis in vivovariability on the
evaluation ofin vitro tests.
With this degree of variability as the
norm, it becomes very difficult to have
confidence that a Draize test will be able to
reveal any real differences between two
mild materials. Yet product developers and
toxicologists often need to be able to detect
with confidence small differences between
candidate products. Thus the need for
alternative tests that may provide more
precise data springs not just from concerns
for animal welfare, but also from the
impreciseness of the animal test and the
desire of toxicologists for better and more
accurate tools.
Development of
Alternative Models
The need to develop alternative in vitro
tests for eye irritation has been apparent for
some time. These alternative assays have
used a diverse set of human and animal
cells, tissues, and even biochemical matrices
(Table 2). What is the strategy that
researchers have used to develop in vitro
assays that model the animal assay? First,
only a few in vitro assays actually attempt to
model the entire eye. In fact, most in vitro
tests that have been proposed are reduction-
ist, i.e., they tend to model only one small
part ofthe complex process of eye irritation.
This has led to a situation where an in vitro
test that may measure only one specific type
ofdamage is compared to a Draize score that
covers several types ofdamage in several tis-
sues. Success at this type of comparison is
more than might reasonably be expected
from asingle in vitro test; thus it makes sense
to think of an eventual test batterywith sev-
eral in vitro tests, each one capable ofdetect-
ing a different type ofdamage. This type of
approach has recently been used by the U.S.
Interagency Regulatory Alternatives Group
(IRAG). This group led an extensive interna-
tional evaluation ofthe state-of-the-art of in
vitro eye irritation tests based on a compari-
son ofin vitro scores to individual animal tis-
sue scores, not to the total combined Draize
score (6).
Ex VivoModels
Figure 2 illustrates the continuum of
reductionist relationships between the
Table2. Characteristics of common in vitroassays.
Assay, reference General description
Neutral red release (16),
neutral red uptake (17)
Fluorescein leakage (14,15)
BCOP(10)
HetCam (25)
Tissue equivalent assay (11)
Enucleated chicken eye (23)
Cytosensor microphysiometera(23)
Irritection (Eytex)b(23)
Pollen tube growth (26)
Red blood cell (19)
SIRC (27)
Target cells (primary or continuous; fibroblasts or
epithelial-like) are grown in submerged monolayerculture
Target cells (primary or continuous; fibroblasts or
epithelial-like) are grown in submerged monolayer culture;
medium may be removed for dosing
Living bovine corneas are treated with test material and
changes in opacity and permeability are measured
by instrument
Chorioallantoic membrane of a chicken egg is treated
Three-dimensional reconstructed tissue (often human)
is grown with top surface exposed to air
Isolated eye of a chicken is treated and subsequent
damage recorded
Cells held over or on a coated sensor are treated and
changes in cellular metabolism are recorded in real time
End point is precipitation ofprotein in a nonviable
commercially supplied matrix. Meantto mimic
opacityformation in the cornea
Tobacco pollen is allowed to germinate in the presence
of test material
Red blood cells are exposed to test material
Target cells (continuous cell line derived from rabbit
cornea) grown in submerged culture atclonal densities
Method of applying test material
Generally increasing dilutions of test material are added to
growth medium until a predetermined end point(generally
cytotoxicity) is reached
Either increasing dilutions of test material are added to growth
medium or cell surface for a settime, or a single concentration
is added forvarying times. End point is induction of permeability
ofthe monolayer
Test materials are applied neat or at in-use concentrations
directly totheepithelial surface ofthe cornea
Test materials are applied neat or at in-use concentrations
directly to the membrane and damage to the membrane is
recorded
Test materials are applied neat or at in-use concentrations
directly to the tissue construct and cell killing is measured
Test materials are applied neat or at in-use concentrations
directly to the tissue construct
Generally increasing dilutions of test material added to growth
medium until a predetermined end point(decrease in
metabolism) is reached
Either dilutions or neattest material is added to a membrane
bullet over a responding protein matrix
Dilutions oftest material used; end point is inhibition of pollen
tube elongation
Dilutions of test material used; lysis (release of hemoglobin)
and hemoglobin denaturation are monitored
Generally increasing dilutions of test material added to growth
medium until a predetermined end point(generally cytotoxicity)
is reached
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Figure2. Relationship of in vitromodels to animal tissue. Diagram illustrating how several specific in vitro assays
have been developed to model different parts of the animal eye. The eye is essentially dissected into its compo-
nent parts and an in vitro assay is developed to represent each part so that specific types of eye injury can be
detected and the mechanism ofaction understood.
whole animal and the in vitromodel. Some
assays focus on a first stage ofreduction, i.e.,
looking just at the isolated eye without any
associated conjunctiva thatwould be present
in the animal. In this type of assay, test
material is applied directly to the excised eye
and any resulting injury is recorded. Such
assays are the enucleated rabbit eye test (7)
and the enucleated chicken eye assay (8).
These tests have been developed by using
the normally discarded eyes from food pro-
duction species such as chickens or from
laboratory animals that have been used for
other purposes.
A second group of in vitro tests models
only the cornea, which is a logical
approach because maintenance of an intact
transparent cornea is the major concern of
ocular safety studies (severe damage to the
cornea can lead to permanent blindness),
and because damage to the cornea con-
tributes more to the Draize score than does
damage to any other ocular tissue. In fact,
one recent study indicated that corneal
score alone is an excellent predictor oftotal
Draize score (9). An example of an assay
that focuses primarily on detecting corneal
damage is the bovine cornea opacity and
permeability (BCOP) test (10). This assay
uses corneas isolated from cattle used for
meat production. With this model the
amount of corneal opacity that has been
induced by a test material can be quantita-
tively measured with an optical instrument,
as opposed to the subjective estimation of
opacity made by gross observation in the
animal test. Damage to the cornea's barrier
function can also be measured with the
BCOP assay.
Another in vitro model designed
to mimic corneal response is the tissue
equivalent assay (TEA) (11). This assay
uses a reconstructed, nonkeratinized
epithelial-like tissue made ofhuman cells,
upon which test materials can be directly
placed. Such tissue is commercially avail-
able (MatTek Corporation, Ashland, MA
and Skin Ethic, Nice, France), although it
can also be produced by the individual
investigator (12). The structure of this
three-dimensional model is meant to simu-
late the epithelial covering of the cornea.
Damage is estimated by measuring the via-
bility of the human cells after treatment.
Because this model is only a reconstructed
tissue, it is not dear how dosely it mimics
the response ofthe epithelial layer of a nor-
mal cornea, but the model has been reason-
ably predictive of ocular irritation (Draize
data) in recent studies (13).
Cell-Based Assays
One step further in the reduction of the
animal eye into less complicated in vitro
models is accomplished using single cell or
monolayer culture assays, which generally
use epithelial cells similar to those that
make up the outer surface ofthe cornea. If
these cells are injured or killed in the ani-
mal, chemicals can more easily penetrate
into the stroma of the cornea and cause
additional damage. This penetration phe-
nomenon is modeled by an in vitro assay
called the fluorescein leakage test (14,15),
in which a single layer ofcells acts as a bar-
rier to a common dye, fluorescein. If the
cells are damaged or killed by a test chemi-
cal they lose their ability to act as a barrier
to fluorescein. The subsequent movement
of this dye through the cell layer can be
measured and is an indicator ofthe amount
ofcell damage.
On a simpler level, one can simply
observe the amount of cell killing that
occurs in a single layer ofhuman or animal
cells (a cytotoxicity assay) and use this
information to infer damage that might
occur to the eye. Examples are the neutral
red release test (16), which uses short
exposure times (such as might occur with
an accidentalsplash to the eye followed by
a quick rinse), and the neutral red uptake
assay (17), which looks atlonger exposure
periods. An extensive review of these
assays has been published as part of the
U.S. IRAG evaluation (18).
Eye irritation can be reduced furtherby
looking at damage to only the cell mem-
branes. An example of this type of test is
the red blood cell assay, where red blood
cells are exposed to test material and mem-
brane lysis is quantitated by measuring the
amount of hemoglobin released (19).
However, we should remember that the
more reductionist the in vitro assay is, the
more likely that itwill onlyrespond to cer-
tain dasses ofchemicals that are likely to
cause eye irritationbythe same mechanism.
Thus only certain types ofeye damage will
bepredictedbyeach in vitro test.
Performance ofthe
in VitroTests
Practicalexperiencewith theperformance of
various in vitro tests either in validation tri-
als or in everyday use has revealed that con-
siderable care must be taken when using the
tests in a routine safety testing program.
Each test seems to exhibit aslightlydifferent
level ofsensitivity to correctlypredict only a
specific range ofchemical dasses. To consis-
tendy give a correct prediction, an in vitro
test mustdo atleast twothings. First it must
appropriately model the exposure kinetics,
i.e., it must accept the test material in the
same physical form as the animal test; it
must be able to beexposed to the same con-
centration as in the animal test; and it must
remain in contact with the test material for
the same amount oftime. Second, the end
points that are developed for the in vitro
assay must be predictive of the underlying
in vivotissue responses and this relationship
mustbedearlyunderstood.
Currently, not all (or even the majority)
ofthe in vitro tests fillly meet these criteria.
Nonetheless, ifthe use and interpretation of
the tests is approached in an empirical fash-
ion and attention is paid to certain key fac-
tors, the results can provide significant
information for toxicologic evaluations.
Thesekey factors indude type ofproduct(s)
to be used, physical characteristics of the
product(s), expected level oftoxicity, resolu-
tion required, intended use ofthe resulting
data, and resources available.
An example ofhow to apply the above
considerations is provided by examining
the second factor, physical characteristics
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ofa product. Because there are two general
forms of in vitro assays-those in which
the substrate is completely immersed in
growth medium (e.g., the neutral red
uptake assay) and those in which the target
surface is available for direct application of
the test material (e.g., TEA)-the water
solubility of a test material should first be
considered. Ifa material is not water solu-
ble, it would be fruitless to attempt to test
it in a neutral red uptake assay because the
test material will likely never actually come
in contact with the target tissue. However,
a topical application assay would be the
logical choice because in this situation the
test material will be applied directly to the
surface of the target cells, ensuring expo-
sure similar to what would occur in vivo.
Examples ofwhich assays are most suitable
depending on the water solubility and
form ofthe test material are as follows:
Water-soluble formations
* BCOP assay
* Fluorescein leakage assays
* Neutral red uptake/release assays
* Chrioallantoic membrane (CAM)-
based systems
* Cytosensor microphysiometer
Hydrophobic formulations
* Topical application assays
* BCOP assays
* Fluorescein leakage assays
* CAM-based systems
Also to be considered is whether to use
dilution-based assays, i.e. assays in which
serial dilutions of the test material are
applied to the target tissue and the end
point is the concentration that causes a cer-
tain response, or assays in which test mate-
rial is only applied undiluted (neat) or at
its in-use concentration.
Both types ofassays have strengths and
weaknesses, as can beseen inTables 3 and4.
A third consideration is the expected
level oftoxicity possessed by the test mate-
rial. Ocular toxicity ranges from very
slight conjunctival redness to full corrosive
destruction of the three primary tissues.
For a single in vitro test to address this full
range, with the desired resolution, would
be challenging. Most in vitro assays are
designed to balance resolution with
dynamic range. Dilution-based assays rely
on the changes in concentration to provide
sensitivity and dynamic range. However,
they are limited in the types of materials
that can be tested. In contrast, the topical
application assays, in which the test materi-
als are applied neat, use time of exposure
(tissue constructs) or the robustness of the
tissue (BCOP) to provide dynamic range.
Table 3. Advantages and disadvantages ofdilution-based assays.
Advantages Disadvantages
Rapid to execute Cannot be used with water-insoluble materials
Most are machine scored Dilution effects may masktoxicity of neat material
Generallyvery cost effective; materials are often batched Change in the physical form, e.g., solids to
(grouped together) solutions
Seem toworkwell with surfactants Buffering effects ofthe medium mayeffecttoxicity
significantly
Often differentiate well between very mild materials Possible reaction ofthe test material with the
solvent
In these assays serial dilutions of the test material are applied to the test system and the end points are the con-
centrations oftest material that cause a selected response.
Table 4. Advantages and disadvantages oftopical application assays.
Advantages Disadvantages
Material istested in its native form, i.e., in the same form Testsubstrate can often be expensive
as an in vivoexposure
Exposure ofthe target tissue can be assured Exposure times may be inconveniently long
In some models, exposure time can be selected to match
expected in vivoexposure
In these assays only the neat or in-use concentration test material is applied to the test system.
The tissue constructs provide high resolution
for assessing potentially very mild (e.g., eye
area cosmetics) to moderately irritating
materials by extending the exposure times.
Their resolution declines for the more
aggressive materials because very short expo-
sures (often a few seconds) are sufficient to
kill the tissue. In contrast, the bovine
cornea, with many layers of epithelium,
does not resolve very mild products without
excessively long exposures. However, it has
the robustness to discriminate at the
medium to highend oftoxicity (20) (Figure
3).The double end points of opacity and
permeability help the assay span the range
from shampoos to industrial cleaners.
Choosing the
Appropriate Assay
The foregoing discussion illustrates that
the choice of an in vitro ocular irritation
assay is not simple. Unless the appropriate
test is chosen, the subsequent results may
be poor predictors ofthe actual ocular irri-
tation potential of a test material. The
previously mentioned key factors are
extremely important and must be consid-
ered every time an in vitro test is contem-
plated. Table 5 gives some additional
information (such as laboratory resources
required and the technical skill needed)
that should also be considered before
choosing an in vitro ocular irritation test.
Need for a
Prediction Model
How will we eventually determine that an
in vitro test produces valid information
| Tissue constructs
BCOP 1~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Degree of ocular irritation
-Extreme Severe Moderate Mild Very mild
Figure 3. Overlapping sensitivity of two types of in
vitroassays. Diagram illustrating how the sensitivity of
the BCOP assay, and assays using tissue constructs,
cover different areas of the ocular irritation scale.
Tissue constructs are effective at the milder end,
whereas the BCOP can correctly characterize differ-
ences between more irritating materials.
that is at least as good as that produced by
animal tests? Generally the accuracy of an
in vitro model is assessed by identifying a
number of materials that have been tested
for ocular irritation in animals and then
retesting the same materials in an in vitro
assay. Both sets of data are then graphed,
plotting the in vitro data on one axis and
the animal data on the other axis, as in
Figure 4. Each point on this graph repre-
sents the eye irritation score of a single
material tested both in vitroand in vivo.
Knowing that both assays give variable
results, we use error bars rather than a sin-
gle point to represent the range of scores
that might be expected if we repeated
each test several times. The data in Figure
4 are from the U.S. Cosmetics, Toiletries,
and Fragrance Association Phase III evalu-
ation of surfactants and surfactant-based
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Table 5. Furthercharacterization ofcommon in vitroassays
In vivotissue or
Test, reference End point irritation scale modeled Resources needed Technician skill level
BCOP(10) Specialized equipment, General laboratory skills
(Total score) Opacity+ permeability Draize MAS commercially available,
(Opacity) Opacity Cornea spectrophotometer
(Permeability) Permeability Cornea/conjunctiva?
Fluorescein leakage (14,15) Permeability Conjunctiva?, cornea Specialized equipment Tissueculture skills
HetCam (25) Vasculardamage, coagulation Draize MAS, conjunctiva General lab equipment General laboratory skills
CAMVA(28) Vasculardamage, coagulation Draize MAS, conjunctiva General lab equipment General laboratory skills
Tissue equivalent assay(11) Cytotoxicity Draize MAS, corneal General tissue culture Sometissueculture skills
epithelium damage labequipment
Neutral red uptake (17) Cytotoxicity Conjunctiva, corneal General tissue culture Tissue culture skills
epithelium damage labequipment, 96-well
plate reader
Neutral red release (16) Cytotoxicity/membrane Conjunctiva, corneal General tissue culture Tissue culture skills
damage? epithelium damage lab equipment, 96-well
plate reader
Enucleated chicken eye (23) Opacity, corneal swelling Corneal damage Specialized equipment General laboratory skills
Cytosensormicrophysiometer (23) Cellular metabolism Conjunctiva, Draize MAS Specialized equipment Tissue culture skills
(expensive)
Irritection (Eytex)a(23) Precipitation Draize MAS Specialized equipment General laboratory skills
Pollen tube growth (26) Cytotoxicity Draize MAS General labequipment, General laboratory skills
spectrophotometer
Red blood cell (19) Membrane lysis Draize MAS General labequipment, General laboratoryskills
spectrophotometer
SIRC (27) Cytotoxicity Conjunctiva General tissue culture Tissue culture skills
labequipment
Abbreviations: CAMVA, chorioallantoic membrane vascular assay; MAS, maximum average score. aInVitro International.
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Figure 4. Surfactant formulations-BCOP permeability score. Graph showing the relationship between the Draize
score of a number of surfactant-containing formulations with permeability measurements made in the in vitro
BCOP assay. The error bars represent± 1 standard deviation. r=0.79.
products (21) and illustrate how data
obtained from the in vitro BCOP assay
compare with the data obtained using
animals. This relationship between in
vitro and in vivo scores, i.e., the algorithm
that allows one to predict an in vivo score
from an in vitro score, is currently called
the prediction model (22). Without such
a known relationship it is impossible not
only to use an in vitro test correctly but
also to conduct a rigorous validation (22).
Notice the variability of in vivo data in
Figure 4, especially when compared to the
more easily reproducible in vitro data.
However, if a relationship is found to be
good enough, the model could be used in
a validation study to test the validity of
both the assay and its prediction model.
However, the difficult question is how
good does this relationship have to be?
Bruner et al. (5) provide a discussion of
what could be expected ifone Draize test is
used to predict the results of a second
Draize test.
Recently two large international valida-
tion trials of in vitro ocular irritation assays
have been completed (23,24). The results
from these studies were mixed, as might be
expected from previous discussion in this
paper concerning the difficulties involved
invalidatingagainstthe Draize test. Whereas
theresults from the firststudy [sponsored by
the European Commission and the British
Home Office (23)] were not encouraging,
the results from the second [sponsored by
the European Cosmetic, Toiletry and
PerfumeryAssociation (24)] indicated that
three of the assays tested satisfied one or
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more ofthe predetermined success criteria.
There were major differences in the scope
of each study, especially in the range of
chemical classes tested; the second study
was limited to chemicals commonly used
in the cosmetics industry. More validation
studies ofthis type can be expected in the
coming years. It is prudent for researches
and toxicologists searching for appropriate
in vitro assays to keep abreast of the find-
ings of current validation studies-and to
take notice ofall the keyfactors involved in
assay selection before deciding which test
to usewith anygiven set oftest materials.
Summary
Before a perfect, quantitative in vitro
ocular irritation model is available, much
basic work still needs to be done to under-
stand mechanistically how injury happens
in the human eye and how to model these
mechanisms in vitro. However, several of
the appropriate in vitro models may
already be in development. The upcoming
results from current and planned valida-
tion studies may tell us just how close any
ofthese assays are to meeting our goals.
Several points need to be emphasized as
we evaluate the state ofreadiness ofin vitro
eye irritation assays:
The eye is a very intricate organ made
up of multiple tissues, each ofwhich
responds differently to injury. Current
animal tests for ocular irritation use a
complex scoring system involving three
important ocular tissues.
* In vitro tests have generally been
designed to model only one-or just a
few-ocular tissues, not the whole eye.
This is very helpful in obtaining more
detailed mechanistic information about
the process of eye irritation. However,
it then potentially leaves us in the
position of having to replace a single
animal test (a Draize test) with multi-
ple in vitro tests. This is not necessar-
ily undesirable, as we will likely learn
more about the actual risk to humans
from a chemical when multiple mech-
anistically understandable tests are
used.
Validation of in vitro ocular irritation
assays will be difficult because the ani-
mal test is not very reproducible and
because the animal test scores repre-
sent a combination of subjective
observations ofmultiple ocular tissues.
Different in vitro tests are suitable for
different types of test materials and
different ranges of toxicity. Careful
consideration must be given to choos-
ing the correct in vitro test for the
required purpose.
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